RY 174.39 2.4016% SHOP 149.115 2.5974% TD-PFM 24.63 -0.0811% TD-PFL 24.7 0.2028% TD 78.325 0.1214% ENB 60.6 1.3039% BN 80.4 1.9787% TRI 226.27 0.7525% CNQ 48.285 2.2771% CP 104.53 1.6038% CNR 151.74 1.5459% BMO 132.69 0.9203% BNS 78.845 0.1715% CSU 4600.2002 2.157% CM 91.15 0.474% MFC 45.79 1.6878% ATD 78.38 1.5285% NGT 60.14 0.0499% TRP 70.15 1.977% SU 57.44 0.5954%
Last update at 2024-11-21T19:22:00Z
AUXLY ANNOUNCES RESULTS OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
Thu 29 Jun 23, 08:30 PMAuxly Furthers Manufacturing Optimization Plan and Related Cost Savings Initiatives
Tue 30 May 23, 08:35 PMAUXLY REPORTS Q1 2023 FINANCIAL RESULTS
Mon 15 May 23, 12:57 PMAUXLY REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS AND PROVIDES OUTLOOK FOR 2023
Fri 31 Mar 23, 11:30 AMAuxly Announces Closing of $3.36 Million Private Placement
Wed 15 Feb 23, 10:30 PMAuxly Announces $3.36 Million Private Placement
Fri 10 Feb 23, 01:30 PMAUXLY REPORTS Q3 2022 FINANCIAL RESULTS
Mon 14 Nov 22, 12:32 PM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | -136.55500M | -50.24000M | -88.11200M | -119.59600M | -69.52200M |
| Minority interest | 0.00000M | 0.01M | -4.41100M | -2.34900M | 3.02M |
| Net income | -130.29300M | -45.91000M | -87.43100M | -108.61800M | -66.98800M |
| Selling general administrative | 37.54M | 36.12M | 43.25M | 50.02M | 47.98M |
| Selling and marketing expenses | 13.13M | 9.60M | 5.61M | 0.27M | 0.40M |
| Gross profit | 17.92M | 19.29M | 11.14M | -3.71100M | -0.18800M |
| Reconciled depreciation | 21.58M | 14.27M | 9.38M | 8.57M | 2.06M |
| Ebit | -46.79300M | -42.00800M | -54.03000M | -61.04500M | -57.82800M |
| Ebitda | -25.21700M | -27.73500M | -44.64600M | -52.47100M | -55.76500M |
| Depreciation and amortization | 21.58M | 14.27M | 9.38M | 8.57M | 2.06M |
| Non operating income net other | - | - | - | - | - |
| Operating income | -46.79300M | -42.00800M | -54.03000M | -61.04500M | -50.62400M |
| Other operating expenses | 142.04M | 122.77M | 97.90M | 70.93M | 51.37M |
| Interest expense | 21.58M | 17.67M | 13.04M | 12.12M | 11.47M |
| Tax provision | -6.26200M | -4.33000M | -0.68100M | -10.97800M | -2.31300M |
| Interest income | 0.34M | 3.85M | 20.41M | 12.07M | 7.24M |
| Net interest income | -21.24100M | -16.07700M | -12.56600M | -8.50900M | -7.47300M |
| Extraordinary items | 0.00000M | 12.16M | -1.53700M | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | -6.26200M | -4.33000M | -0.68100M | -10.97800M | -2.31300M |
| Total revenue | 94.47M | 83.83M | 50.80M | 8.35M | 0.75M |
| Total operating expenses | 65.49M | 58.23M | 58.24M | 58.87M | 50.44M |
| Cost of revenue | 76.55M | 64.54M | 39.66M | 12.06M | 0.94M |
| Total other income expense net | -89.76200M | -8.23200M | -34.08200M | -58.55100M | -18.89800M |
| Discontinued operations | - | 12.16M | -1.53700M | -1.53700M | -1.53700M |
| Net income from continuing ops | -130.29300M | -45.91000M | -87.43100M | -108.61800M | -67.20900M |
| Net income applicable to common shares | -130.29300M | -33.73900M | -85.42600M | -102.57400M | -66.98800M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 261.90M | 331.82M | 450.42M | 378.96M | 411.59M |
| Intangible assets | 29.88M | 45.47M | 74.20M | 74.26M | 77.42M |
| Earning assets | - | - | - | - | - |
| Other current assets | 1.52M | 3.13M | 14.93M | 12.68M | 0.23M |
| Total liab | 210.86M | 246.13M | 242.31M | 187.43M | 149.69M |
| Total stockholder equity | 51.05M | 90.41M | 212.52M | 195.94M | 264.25M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 0.49M | 0.71M | 1.30M | 7.36M | 2.77M |
| Common stock | 446.56M | 444.76M | 436.51M | 394.57M | 384.43M |
| Capital stock | 446.56M | 444.76M | 436.51M | 394.57M | 384.43M |
| Retained earnings | -483.27200M | -438.76100M | -308.46800M | -274.72900M | -189.30300M |
| Other liab | - | - | 20.04M | 22.49M | 23.60M |
| Good will | - | 0.00000M | 24.29M | 28.59M | 29.00M |
| Other assets | - | 0.09M | 1.58M | 1.78M | 15.65M |
| Cash | 16.16M | 14.64M | 14.75M | 21.21M | 44.13M |
| Cash and equivalents | - | 14.64M | 14.75M | 21.21M | 44.13M |
| Total current liabilities | 106.97M | 92.69M | 53.65M | 45.01M | 29.90M |
| Current deferred revenue | 0.00000M | - | 0.29M | 5.66M | 4.33M |
| Net debt | 142.88M | 178.96M | 175.35M | 103.47M | 55.59M |
| Short term debt | 65.18M | 58.93M | 21.49M | 4.75M | 3.95M |
| Short long term debt | 61.35M | 54.67M | 17.45M | 3.28M | 2.71M |
| Short long term debt total | 159.04M | 193.59M | 190.10M | 124.68M | 99.72M |
| Other stockholder equity | 39.50M | -30.54200M | 44.85M | 41.60M | 38.90M |
| Property plant equipment | - | 195.27M | 226.48M | 95.35M | 85.18M |
| Total current assets | 65.99M | 89.90M | 119.97M | 91.87M | 91.60M |
| Long term investments | 1.09M | 1.09M | 3.90M | 87.11M | 112.74M |
| Net tangible assets | - | - | 114.03M | 93.09M | 158.24M |
| Short term investments | 0.14M | 0.14M | 0.14M | 0.29M | 0.31M |
| Net receivables | 16.73M | 17.53M | 31.21M | 13.47M | 15.61M |
| Long term debt | 81.38M | 119.80M | 151.36M | 110.53M | 90.88M |
| Inventory | 31.43M | 54.46M | 58.94M | 44.22M | 27.06M |
| Accounts payable | 41.30M | 33.05M | 30.57M | 27.24M | 20.23M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 48.26M | 84.41M | 84.48M | 76.09M | 69.13M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 5.98M | 0.09M | 1.58M | 1.78M | 15.65M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 195.92M | 241.92M | 330.45M | 287.09M | 319.99M |
| Capital lease obligations | 16.31M | 19.12M | 21.30M | 10.88M | 6.14M |
| Long term debt total | - | 134.67M | 168.61M | 119.94M | 95.78M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | 1.18M | 9.34M | 6.01M | -75.19700M | -51.13700M |
| Change to liabilities | 2.87M | 0.18M | 5.30M | 1.07M | 0.41M |
| Total cashflows from investing activities | 1.18M | 17.33M | -14.53000M | -134.81800M | -82.78300M |
| Net borrowings | - | -19.55400M | 7.17M | 40.82M | 99.50M |
| Total cash from financing activities | 1.18M | 26.40M | 24.74M | 46.36M | 304.75M |
| Change to operating activities | 9.98M | -6.25600M | 23.41M | -12.33400M | -7.46000M |
| Net income | -130.29300M | -45.91000M | -87.43100M | -108.61800M | -67.20900M |
| Change in cash | -0.11800M | -5.90300M | -22.92000M | -167.57300M | 178.25M |
| Begin period cash flow | 14.75M | 20.66M | 44.13M | 211.71M | 33.45M |
| End period cash flow | 14.64M | 14.75M | 21.21M | 44.13M | 211.71M |
| Total cash from operating activities | -2.48100M | -49.62900M | -33.12800M | -79.11900M | -43.71400M |
| Issuance of capital stock | 7.94M | 44.94M | 12.72M | 5.21M | 109.36M |
| Depreciation | 21.58M | 14.27M | 9.38M | 8.57M | 2.06M |
| Other cashflows from investing activities | 10.37M | -0.00300M | -0.16300M | -31.94900M | -2.96300M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | -3.21500M | -6.93000M | -19.48900M | -24.39500M | -1.60900M |
| Change to account receivables | 10.41M | -16.65400M | -8.97200M | -15.11900M | -2.18200M |
| Sale purchase of stock | 7.94M | 46.15M | 12.91M | 5.54M | 205.25M |
| Other cashflows from financing activities | 15.51M | 49.27M | 19.14M | 121.30M | 195.89M |
| Change to netincome | - | -0.50600M | 43.00M | 53.02M | 34.06M |
| Capital expenditures | 9.19M | 0.38M | 20.73M | 37.80M | 17.95M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | 20.04M | -29.65700M | 1.40M | -36.83600M | -12.85100M |
| Stock based compensation | 4.02M | 1.43M | 4.35M | 12.55M | 20.41M |
| Other non cash items | 88.43M | 14.56M | 39.85M | 56.19M | 16.18M |
| Free cash flow | -11.67300M | -50.00700M | -53.85700M | -116.92100M | -61.66800M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
| Company | Change (CAD) | Price (CAD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| XLY Auxly Cannabis Group Inc |
0.005 14.29% | 0.04 | - | - | 0.57 | 0.59 | 1.17 | 86.85 |
| BHC Bausch Health Companies Inc |
-0.11 0.96% | 11.37 | - | 2.23 | 0.50 | 18.74 | 2.56 | 9.13 |
| CURA Curaleaf Holdings Inc. |
-0.175 5.93% | 2.77 | - | 138.89 | 1.62 | 1.66 | 1.73 | 10.18 |
| TLRY Tilray Inc |
0.03 1.38% | 1.83 | - | 1000.00 | 2.17 | 0.36 | 1.69 | -2.299 |
| CRON Cronos Group Inc |
0.06 2.15% | 2.85 | - | - | 10.18 | 0.70 | 0.02 | -1.9458 |
Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. It focuses on developing, manufacturing, and distributing cannabis products for wellness and recreational consumers. The company offers cannabis products under various forms, including vape catridges, infused pre-rolls, pre-rolled, vape pens, milled and dried flower, concentrates, chocolates, soft chews, oil drops, capsules, and topicals under the KOLAB PROJECT, Dosecann, BACK FORTY, Foray, and Parcel brand names. It sells its products through supply arrangements with provincial control boards and distributors, medical cannabis sales channels, and retailers, as well as to authorized wholesalers. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. The company was incorporated in 1987 and is headquartered in Toronto, Canada.
777 Richmond Street West, Toronto, ON, Canada, M6J 0C2
| Name | Title | Year Born |
|---|---|---|
| Mr. Hugo M. Alves | CEO & Director | 1972 |
| Mr. Michael David Lickver | Pres | 1986 |
| Mr. Brian Schmitt | Chief Financial Officer | NA |
| Mr. Ron Fichter | Gen. Counsel & Corp. Sec. | NA |
| Mr. Andrew MacMillan | Sr. VP of Commercial | NA |
| Mr. Alan Cooke | Sr. VP of Operations | NA |
| Ms. Carla Nawrocki | Sr. VP of Corp. Devel. & Strategy | NA |
| Mr. Ian Peter Rapsey | Chief Creative Officer | 1977 |
| Mr. Kevin Furet | Chief Cultivation & Genetics Officer | NA |
| Mr. Vladimir Klacar | Sr. VP of Regulatory Affairs & Planning | 1989 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
CA 
AU
UK
US
NZ
Please wait processing your request...